May 21, 2019 MIPS, the world leader in brain protection systems within helmet-based safety, has today entered into an acquisition agreement for assets that further enhances MIPS’ product offering and safety solutions. The acquisition comprises the brand FLUID and related patent rights a... read more

Oslo, Norway, 21 May 2019 Nordic Nanovector ASA (OSE: NANO) announces that following a safety review of the first patients in the ongoing Archer-1 (LYMRIT 37-07) trial investigating Betalutin® (177Lu-satetraxetan-lilotomab) in combination with rituximab (RTX) in second-line follicular ... read more

Boston, US, 09.30 ET, 21 May 2019 – BONESUPPORTTM, an emerging leader in orthobiologics for the management of bone voids, is now the exclusive distributor of CERAMENT® in the United States. CERAMENT is now sold exclusively by BONESUPPORT’s own commercial organization – a net... read more

May 21, 2019 - Regulatory press release Press releases Summary of Q1 “The initiation of the filing process for melflufen in the US is a major milestone for Oncopeptides.” Financial overview January 1 – March 31, 2019 Net sales amounted to SEK 0.0 M (0.0) Loss for th... read more

- Vofatamab activates immune changes in immunologically cold tumors and in combination increases patient response rates - - Data from FIERCE-22 Trial in Patients with Metastatic Bladder Cancer Presented at AACR Bladder Cancer Conference - SAN LEANDRO, Calif., May 20, 2019—Rainier Therapeutics,... read more